Premium
Folate, vitamin B 12 and cognitive impairment in patients with Alzheimer's disease
Author(s) -
Levitt A. J.,
Karlinsky H.
Publication year - 1992
Publication title -
acta psychiatrica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.849
H-Index - 146
eISSN - 1600-0447
pISSN - 0001-690X
DOI - 10.1111/j.1600-0447.1992.tb03270.x
Subject(s) - dementia , cognitive impairment , medicine , mini–mental state examination , disease , vitamin b , alzheimer's disease , cognition , correlation , gastroenterology , vitamin , psychology , psychiatry , geometry , mathematics
This study examines the relationship between folate, vitamin B 12 and severity of cognitive impairment in patients with Alzheimer's disease (AD) as compared with other disorders associated with cognitive impairment. The patients were 97 consecutive referrals to an AD clinic. Forty patients had either possible or probable AD. 31 had other dementias (OD) and 26 had mild cognitive impairment (cognitively impaired, not demented; CIND). Patients had blood drawn for serum, red cell folate and B 12 , as well as other biochemical indicators of nutrition, within 24 h of the Mini‐Mental State Examination (MMSE). In the AD group, only B 12 was significantly correlated with MMSE. Using regression analysis, B 12 contributed significantly to variance in MMSE. There was no correlation between MMSE and serum, red cell folate or B 12 in the OD or CIND group and no significant correlation between MMSE and other nutritional indices in any group. These findings suggest the possibility of a specific relationship between B 12 levels and severity of cognitive impairment in patients with AD.